BiO2 Medical, Inc. was founded in December 2006 by Luis F. Angel, MD, Christopher E. Banas, and Paul Castella, PhD. The company was formed to design, develop, and subsequently manufacture a range of medical products. BiO2 Medical has corporate headquarters in San Antonio, TX, and a research and development (R&D) and manufacturing facility in Golden, CO. The Golden facility is certified per ISO 13485:2003 and includes a state of the art 1,000 ft2 clean room certified as a class 8 (100,000) controlled environment (CER), which is currently dedicated to the production of the Angel™ Catheter.
BiO2 Medical’s current primary objective is to develop and commercialize the Angel™ Catheter as the de facto standard of care device for the prevention of PE related mortality and morbidity in critically ill patients worldwide.
The founders and employees of BiO2 Medical have a proven track record of successfully innovating, developing, and commercializing novel medical devices that address current important medical problems in both US and overseas markets. BiO2 Medical’s founders have been responsible for the regulatory approval (FDA or CE Mark) of more than 100 medical device or diagnostic products, and have contributed to numerous successful start-up medical device companies, including Advanced Bio Prosthetic Surfaces (novel thin film Nitinol technology for stent and device manufacture), CardioSpectra (high speed, high resolution optical coherence tomography catheter devices for coronary imaging), ViroXis Corporation (botanical topical drug development), Aeon BioScience (recombinant elastin based polymers for biocompatible device coating and tissue implants), and Xenotope Diagnostics (novel rapid test for Trichomonas).